about
Social regulation of gene expression in human leukocytesThe frameshift signal of HIV-1 involves a potential intramolecular triplex RNA structureComparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertasesBarrier-to-autointegration factor BAF binds p55 Gag and matrix and is a host component of human immunodeficiency virus type 1 virionsT helper cell activation and human retroviral pathogenesisRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsThe Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channelsInduction of interleukin-12 (IL-12) by recombinant glycoprotein gp120 of human immunodeficiency virus type 1 in human monocytes/macrophages: requirement of gamma interferon for IL-12 secretionFunctional impairment of central memory CD4 T cells is a potential early prognostic marker for changing viral load in SHIV-infected rhesus macaquesMobilization of HIV spread by diaphanous 2 dependent filopodia in infected dendritic cellsUse of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 regionCytopathic Mechanisms of HIV-1The anti-HIV pentameric pseudopeptide HB-19 is preferentially taken up in vivo by lymphoid organs where it forms a complex with nucleolinThe glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene productMultibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophagesInhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFATChemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptaseAge-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected childrenModeling of HIV-1 infection: insights to the role of monocytes/macrophages, latently infected T4 cells, and HAART regimesResistance mutations outside the integrase coding region have an effect on human immunodeficiency virus replicative fitness but do not affect its susceptibility to integrase strand transfer inhibitorsCD4 depletion in HIV-infected haemophilia patients is associated with rapid clearance of immune complex-coated CD4+ lymphocytesLower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptaseConvergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progressionToward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1.Protein intrinsic disorder toolbox for comparative analysis of viral proteins.Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes.Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytes.Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayersAIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1.Morphine enhances HIV infection of neonatal macrophages.The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus.Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.Analysis of human immunodeficiency virus cytopathicity by using a new method for quantitating viral dynamics in cell culture.Differential antiviral activities and intracellular metabolism of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in human cells.HIV-1 Transmission, Replication Fitness and Disease Progression.Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes.DNA and RNA-based vaccines: principles, progress and prospects.Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosisFunctional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.
P2860
Q21184112-D7C4819A-606E-400B-A0F9-B93385F1EA66Q24534107-E6E1D5AD-CC43-4DAE-84B8-EC16881B86EDQ24534205-FF07558D-B957-4662-99E4-2D6F1A8443F1Q24628754-69CB3185-8B2B-4FC8-A16B-317C78E65D86Q24650854-C0423FE5-DCD6-40C3-B67F-6BED8468140CQ24651506-417B713F-3A62-4095-97A8-E6C50F137FE4Q24680307-12981058-CAB9-4D87-85FA-1A4985130C07Q24682710-93DDD9C3-88B4-44A0-B684-40E639E4D307Q27342763-DC294936-BFA8-4FAD-B950-172E6C8E92A9Q27345158-48C0761F-B87E-457A-A1C5-10C1600C5F1EQ27480326-3FAEF876-66D3-4565-99AC-2D8956217686Q27485043-C8670A4C-4B8F-48D6-86E6-3A20E9D1E71DQ28363541-DA91EFC7-2969-4531-8308-D0E746BA2E39Q28368083-E9A6469A-6936-4F39-A9F5-78813529196CQ28369349-1668F20C-49E0-422A-93DB-D765EA31445BQ28379490-9918A2CB-125B-4BD6-8CD8-EF7CBE28F7BCQ28379510-CF4D591C-3A1B-4DA4-B06A-4E64A029BAA4Q28483967-351FDE8B-9FE9-4210-96AC-FE3E2701D4E8Q28484046-FAF9C1EE-11AE-4FC0-9091-BA8E89B19C44Q28533830-EB3D82AF-BE2E-48A8-AD23-26760675CE0AQ29026902-A2AAE05C-1964-4D01-8A3C-88CBD25726E2Q29619994-CCC514B6-29A2-4ECF-9D46-6FEEDA40ED86Q30416671-8D2FF77C-E6F9-4971-86D7-A08225AF1B0CQ31126790-8D6E561B-4579-4691-8DCE-82FF19C6B059Q33373579-84CD4870-45D4-4DFC-8685-D52C6B00A5AEQ33572329-1AF6B9DD-B7EB-400E-92C0-D75D0DEEBB28Q33586479-D03B0D3D-3E93-4CCB-AC95-F2E7E904C1B9Q33601511-11206AD4-74CE-4D38-91E2-9862957C786BQ33604959-ECBE687A-519D-4745-AB23-9F44F97EF9DEQ33653627-C83F2B93-7F17-45EC-9559-3B68A62C8028Q33669599-DC5E4989-A903-4975-94D6-144F6DAE2B75Q33676449-9391587F-C566-416C-AA71-3499B59C8958Q33683180-DD8A4D77-7DDE-4D48-A0E7-E8480AEF1EDEQ33707384-EB8B54EA-861D-4ED9-9254-A3496EA6D08AQ33754889-95C9CC56-A1A1-49A9-ABB0-74A2A8ABC442Q33758570-334A46CF-5501-494D-97D4-18D4F26B378BQ33783763-75164C4E-5856-4035-9FC3-9EDD0BE78D1BQ33783789-40BDE8F9-CB2E-43F4-A545-9FD600D18E5EQ33783919-9ED2CDE8-0C97-4717-83B2-DE0DAA4C3375Q33787316-B7C487F7-55B5-4277-BE97-74A5B064BE7A
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մարտին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Pathogenesis of human immunodeficiency virus infection
@ast
Pathogenesis of human immunodeficiency virus infection
@en
Pathogenesis of human immunodeficiency virus infection
@nl
type
label
Pathogenesis of human immunodeficiency virus infection
@ast
Pathogenesis of human immunodeficiency virus infection
@en
Pathogenesis of human immunodeficiency virus infection
@nl
prefLabel
Pathogenesis of human immunodeficiency virus infection
@ast
Pathogenesis of human immunodeficiency virus infection
@en
Pathogenesis of human immunodeficiency virus infection
@nl
P2860
P1476
Pathogenesis of human immunodeficiency virus infection
@en
P2093
P2860
P304
P407
P577
1993-03-01T00:00:00Z